483 related articles for article (PubMed ID: 21293464)
1. A functionally characterized test set of human induced pluripotent stem cells.
Boulting GL; Kiskinis E; Croft GF; Amoroso MW; Oakley DH; Wainger BJ; Williams DJ; Kahler DJ; Yamaki M; Davidow L; Rodolfa CT; Dimos JT; Mikkilineni S; MacDermott AB; Woolf CJ; Henderson CE; Wichterle H; Eggan K
Nat Biotechnol; 2011 Mar; 29(3):279-86. PubMed ID: 21293464
[TBL] [Abstract][Full Text] [Related]
2. Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells.
Koehler KR; Tropel P; Theile JW; Kondo T; Cummins TR; Viville S; Hashino E
BMC Neurosci; 2011 Aug; 12():82. PubMed ID: 21831300
[TBL] [Abstract][Full Text] [Related]
3. Generation of mice derived from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
[TBL] [Abstract][Full Text] [Related]
4. Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage.
Yang G; Hong H; Torres A; Malloy KE; Choudhury GR; Kim J; Daadi MM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227600
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC Scorecard(TM) Panel.
Fergus J; Quintanilla R; Lakshmipathy U
Methods Mol Biol; 2016; 1307():25-37. PubMed ID: 25138722
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell technology in regenerative medicine and biology.
Pei D; Xu J; Zhuang Q; Tse HF; Esteban MA
Adv Biochem Eng Biotechnol; 2010; 123():127-41. PubMed ID: 20549468
[TBL] [Abstract][Full Text] [Related]
7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
8. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
10. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
[TBL] [Abstract][Full Text] [Related]
11. Human Pluripotent Stem Cells (iPSC) Generation, Culture, and Differentiation to Lung Progenitor Cells.
Ghaedi M; Niklason LE
Methods Mol Biol; 2019; 1576():55-92. PubMed ID: 27628133
[TBL] [Abstract][Full Text] [Related]
12. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
Montgomery A; Wong A; Gabers N; Willerth SM
Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
[TBL] [Abstract][Full Text] [Related]
13. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.
Hu BY; Weick JP; Yu J; Ma LX; Zhang XQ; Thomson JA; Zhang SC
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4335-40. PubMed ID: 20160098
[TBL] [Abstract][Full Text] [Related]
14. Culture systems for pluripotent stem cells.
Ulloa-Montoya F; Verfaillie CM; Hu WS
J Biosci Bioeng; 2005 Jul; 100(1):12-27. PubMed ID: 16233846
[TBL] [Abstract][Full Text] [Related]
15. Generation of human induced pluripotent stem cells from dermal fibroblasts.
Lowry WE; Richter L; Yachechko R; Pyle AD; Tchieu J; Sridharan R; Clark AT; Plath K
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2883-8. PubMed ID: 18287077
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
[TBL] [Abstract][Full Text] [Related]
17. Non-Human Primate iPSC Generation, Cultivation, and Cardiac Differentiation under Chemically Defined Conditions.
Stauske M; Rodriguez Polo I; Haas W; Knorr DY; Borchert T; Streckfuss-Bömeke K; Dressel R; Bartels I; Tiburcy M; Zimmermann WH; Behr R
Cells; 2020 May; 9(6):. PubMed ID: 32485910
[TBL] [Abstract][Full Text] [Related]
18. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.
Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H
J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419
[TBL] [Abstract][Full Text] [Related]
19. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
Boraas LC; Guidry JB; Pineda ET; Ahsan T
PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
[TBL] [Abstract][Full Text] [Related]
20. Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells.
Fidan K; Ebrahimi A; Çağlayan ÖH; Özçimen B; Önder TT
Methods Mol Biol; 2016; 1353():215-31. PubMed ID: 26126451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
